Seven Days of Gamma-Hydroxybutyrate (GHB) Use Produces Severe Withdrawal

Annals of Emergency Medicine

Volumn 48, Issue 2, 2006, Pages 219-220

  Perez, Eric ^a   Chu, Jason ^a   Bania, Theodore ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; LORAZEPAM; SODIUM CHLORIDE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; LABORATORY TEST; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; SINUS TACHYCARDIA; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HUMANS; SODIUM OXYBATE; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 33745943770     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2006.03.040     Document Type: Letter

References (5)

1. Dyer J.E., Roth B., and Hyma B. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med. 37 (2001) 147-153
2. McDaniel C.H., and Miotto K. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal. five case studies. J Psychoactive Drugs 33 (2001) 143-149
3. Miotto K., Darakjian J., Basch J., et al. Gamma-hydroxybutyricacid. patterns of use, effects and withdrawal. Am J Addict. 10 (2001) 232-241
4. Isbell H., Fraser H.F., Wikler A., et al. An experimental study of the etiology of "rum fits" and delirium tremens. Q J Stud Alcohol 16 (1953) 1-33
5. Cammarano W.B., Pittit J.F., Weitz S., et al. Acute withdrawal syndrome related to the administration of analgesia and sedation in adult intensive care patients. Crit Care Med. 26 (1998) 676-684